FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890614044> ?p ?o ?g. }

• W2890614044 endingPage "1369" @default.
• W2890614044 startingPage "1364" @default.
• W2890614044 abstract "Non-small cell lung cancer (NSCLC) with activating EGFR mutations in exon 19 and 21 typically responds to EGFR tyrosine kinase inhibitors (TKI); however, for some patients, responses last only a few months. The underlying mechanisms of such short responses have not been fully elucidated. Here, we sequenced the genomes of 16 short-term responders (SR) that had progression-free survival (PFS) of less than 6 months on the first-generation EGFR TKI and compared them to 12 long-term responders (LR) that had more than 24 months of PFS. All patients were diagnosed with advanced lung adenocarcinoma and harbored EGFR 19del or L858R mutations before treatment. Paired tumor samples collected before treatment and after relapse (or at the last follow-up) were subjected to targeted next-generation sequencing of 416 cancer-related genes. SR patients were significantly younger than LR patients (P < .001). Collectively, 88% of SR patients had TP53 variations compared to 13% of LR patients (P < .001). Additionally, 37.5% of SR patients carried EGFR amplifications compared to 8% of LR patients. Other potential primary resistance factors were also identified in the pretreatment samples of 12 SR patients (75%), including PTEN loss; BIM deletion polymorphism; and amplifications of EGFR, ERBB2, MET, HRAS, and AKT2. Comparatively, only three LR patients (25%) were detected with EGFR or AKT1 amplifications that could possibly exert resistance. The diverse preexisting resistance mechanisms in SR patients revealed the complexity of defining treatment strategies even for EGFR-sensitive mutations." @default.
• W2890614044 created "2018-09-27" @default.
• W2890614044 creator A5003742311 @default.
• W2890614044 creator A5020104705 @default.
• W2890614044 creator A5032428632 @default.
• W2890614044 creator A5041181413 @default.
• W2890614044 creator A5050583771 @default.
• W2890614044 creator A5064805356 @default.
• W2890614044 date "2018-12-01" @default.
• W2890614044 modified "2023-10-02" @default.
• W2890614044 title "Short-Term Responders of Non–Small Cell Lung Cancer Patients to EGFR Tyrosine Kinase Inhibitors Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms" @default.
• W2890614044 cites W1496700764 @default.
• W2890614044 cites W1555902516 @default.
• W2890614044 cites W1712737666 @default.
• W2890614044 cites W1842992197 @default.
• W2890614044 cites W1848191009 @default.
• W2890614044 cites W1985271346 @default.
• W2890614044 cites W2043696829 @default.
• W2890614044 cites W2068122382 @default.
• W2890614044 cites W2111662961 @default.
• W2890614044 cites W2158794766 @default.
• W2890614044 cites W2161821474 @default.
• W2890614044 cites W2166084034 @default.
• W2890614044 cites W2180481128 @default.
• W2890614044 cites W2337836619 @default.
• W2890614044 cites W2371565037 @default.
• W2890614044 cites W2405513305 @default.
• W2890614044 cites W2416111151 @default.
• W2890614044 cites W2534288116 @default.
• W2890614044 cites W2561510608 @default.
• W2890614044 cites W2581103010 @default.
• W2890614044 cites W2588764077 @default.
• W2890614044 cites W2593741942 @default.
• W2890614044 cites W2598551510 @default.
• W2890614044 cites W2610580219 @default.
• W2890614044 cites W2655216406 @default.
• W2890614044 cites W2766316939 @default.
• W2890614044 cites W2791187138 @default.
• W2890614044 cites W2792218462 @default.
• W2890614044 cites W2794883050 @default.
• W2890614044 cites W3012536676 @default.
• W2890614044 doi "https://doi.org/10.1016/j.tranon.2018.08.010" @default.
• W2890614044 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6132175" @default.
• W2890614044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30196239" @default.
• W2890614044 hasPublicationYear "2018" @default.
• W2890614044 type Work @default.
• W2890614044 sameAs 2890614044 @default.
• W2890614044 citedByCount "18" @default.
• W2890614044 countsByYear W28906140442019 @default.
• W2890614044 countsByYear W28906140442020 @default.
• W2890614044 countsByYear W28906140442021 @default.
• W2890614044 countsByYear W28906140442022 @default.
• W2890614044 countsByYear W28906140442023 @default.
• W2890614044 crossrefType "journal-article" @default.
• W2890614044 hasAuthorship W2890614044A5003742311 @default.
• W2890614044 hasAuthorship W2890614044A5020104705 @default.
• W2890614044 hasAuthorship W2890614044A5032428632 @default.
• W2890614044 hasAuthorship W2890614044A5041181413 @default.
• W2890614044 hasAuthorship W2890614044A5050583771 @default.
• W2890614044 hasAuthorship W2890614044A5064805356 @default.
• W2890614044 hasBestOaLocation W28906140441 @default.
• W2890614044 hasConcept C104317684 @default.
• W2890614044 hasConcept C1167327 @default.
• W2890614044 hasConcept C121608353 @default.
• W2890614044 hasConcept C126322002 @default.
• W2890614044 hasConcept C143998085 @default.
• W2890614044 hasConcept C170493617 @default.
• W2890614044 hasConcept C2776256026 @default.
• W2890614044 hasConcept C2777609662 @default.
• W2890614044 hasConcept C2781182431 @default.
• W2890614044 hasConcept C2781187634 @default.
• W2890614044 hasConcept C36823959 @default.
• W2890614044 hasConcept C42362537 @default.
• W2890614044 hasConcept C502942594 @default.
• W2890614044 hasConcept C526805850 @default.
• W2890614044 hasConcept C54355233 @default.
• W2890614044 hasConcept C62478195 @default.
• W2890614044 hasConcept C71924100 @default.
• W2890614044 hasConcept C86554907 @default.
• W2890614044 hasConcept C86803240 @default.
• W2890614044 hasConceptScore W2890614044C104317684 @default.
• W2890614044 hasConceptScore W2890614044C1167327 @default.
• W2890614044 hasConceptScore W2890614044C121608353 @default.
• W2890614044 hasConceptScore W2890614044C126322002 @default.
• W2890614044 hasConceptScore W2890614044C143998085 @default.
• W2890614044 hasConceptScore W2890614044C170493617 @default.
• W2890614044 hasConceptScore W2890614044C2776256026 @default.
• W2890614044 hasConceptScore W2890614044C2777609662 @default.
• W2890614044 hasConceptScore W2890614044C2781182431 @default.
• W2890614044 hasConceptScore W2890614044C2781187634 @default.
• W2890614044 hasConceptScore W2890614044C36823959 @default.
• W2890614044 hasConceptScore W2890614044C42362537 @default.
• W2890614044 hasConceptScore W2890614044C502942594 @default.
• W2890614044 hasConceptScore W2890614044C526805850 @default.
• W2890614044 hasConceptScore W2890614044C54355233 @default.
• W2890614044 hasConceptScore W2890614044C62478195 @default.
• W2890614044 hasConceptScore W2890614044C71924100 @default.
• W2890614044 hasConceptScore W2890614044C86554907 @default.

• next